imagen laboratorio

Pipeline

  1. Home
  2. Pipeline
SRB1 (hematologic tumors)

Discovery

Discovery
in vitro

Preclinical

in vivo
Regulatory
Phase I

Clinical phases

Phase II
Phase III
SRB1 (solid tumors)

Discovery

Discovery

Preclinical

in vitro
in vivo
Regulatory

Clinical phases

Phase I
Phase II
Phase III
SRB22, anti-HER3-TRAIL bifunctional (Licensed to Ellipses Pharma)

Discovery

Discovery

Preclinical

in vitro
in vivo
Regulatory

Clinical phases

Phase I
Phase II
Phase III
SRB17, anti-HER3 mAb (Licensed to Debiopharm)

Discovery

Discovery

Preclinical

in vitro
in vivo
Regulatory

Clinical phases

Phase I
Phase II
Phase III
SRB19, anti-HER3-EGFR bispecific (Licensed to Debiopharm)

Discovery

Discovery

Preclinical

in vitro
in vivo
Regulatory

Clinical phases

Phase I
Phase II
Phase III
SRB21, anti-HER3-HER2 bispecific (Licensed to Debiopharm)

Discovery

Discovery

Preclinical

in vitro
in vivo
Regulatory

Clinical phases

Phase I
Phase II
Phase III
Axencia Galega de Innovación